Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia

Published:2014-08 Issue:8 Volume:38 Page:891-895
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Gozzetti Alessandro,Candi Veronica,Fabbri Alberto,Schiattone Luana,Cencini Emanuele,Lauria Francesco,Frasconi Adele,Crupi Rosaria,Raspadori Donatella,Papini Giulia,Defina Marzia,Bartalucci Giulia,Bocchia Monica

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference22 articles.

1. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

2. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia;Tam;Blood,2008

3. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial;Hallek;Lancet,2010

4. Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia;Shvidel;Leuk Lymphoma,2003

5. Favorable impact of low dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment of low grade non-Hodgkin's lymphomas;Bocchia;Haematologica,1999

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma;Journal of Chemotherapy;2023-12-11

2. Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany;Clinical and Experimental Medicine;2023-11-18

3. Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia, Focusing on Long Term Cytopenias Before and After the Era of Targeted Therapies;Pathology and Oncology Research;2021-04-27

4. Low‐dose fludarabine and cyclophosphamide combined with rituximab in the first‐line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long‐term results of project Q‐lite by the Czech CLL Study Group;British Journal of Haematology;2021-02-22

5. Real-life Diagnostic and Therapeutic Approach to CLL: A New Proposal from an Expert Panel in Tuscany Region;Farmeconomia. Health economics and therapeutic pathways;2020-02-06